Women's Heart Health: Difference between revisions

no edit summary
No edit summary
No edit summary
Line 5: Line 5:
==Facts & Figures==
==Facts & Figures==
===Epidemiology===
===Epidemiology===
Cardiovascular disease (CVD) is the leading cause of death in women worldwide. According to the Global Burden of disease CVD caused almost 32% of deaths in women worldwide vs. 27% in men(AHA: statistical fact sheet june 2010). In Europe 54% of al female deaths are from CVD vs. 43% men (British heart Foundation/heartstats.). After at least two decades of growing awareness regarding sex differences in coronary artery disease, the evolving knowledge of the clinical consequences is emerging. Although recent  reports document decreases in CHD mortality for women, reductions lag behind those realized for men (2 Heron MP, Hoyert DL, Xu J, Scott C, Tejada-Vera B. Deaths: preliminary data for 2006. Natl Vital Stat Rep 2008;56:1–52). Another worrying fact is that we see a mortality increase among younger women (3. Ford ES, Capewell S. Coronary heart disease mortality among Young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol 2007;50:2128 –32.),
Cardiovascular disease (CVD) is the leading cause of death in women worldwide. According to the Global Burden of disease CVD caused almost 32% of deaths in women worldwide vs. 27% in men.<cite>1</cite> In Europe 54% of all female deaths are from CVD vs. 43% men.<cite>2</cite> After at least two decades of growing awareness regarding sex differences in coronary artery disease, the evolving knowledge of the clinical consequences is emerging. Although recent  reports document decreases in CHD mortality for women, reductions lag behind those realized for men.<cite>3</cite> Another worrying fact is that we see a mortality increase among younger women.<cite>4</cite>
3).


In general cardiovascular events among women appear approximately 7-10 years later in women than in men. The lower incidence of CVD in premenopausal women compared with men of similar age and the menopause associated increase in CVD have long suggested that estrogens underlie a protective effect on the cardiovascular system for women.  
In general cardiovascular events among women appear approximately 7-10 years later in women than in men. The lower incidence of CVD in premenopausal women compared with men of similar age and the menopause associated increase in CVD have long suggested that estrogens underlie a protective effect on the cardiovascular system for women.  
Line 32: Line 31:
When obstructive coronary artery is absent these women do not receive the proper preventive medication as the atherosclerosis in the microvasculature progresses, leading to ischemia an possibly fatal arrhythmia’s.  After menopause it is known that the microvascular atherosclerosis can progress towards more pronounced atherosclerosis with eventually obstructive plaque formation.
When obstructive coronary artery is absent these women do not receive the proper preventive medication as the atherosclerosis in the microvasculature progresses, leading to ischemia an possibly fatal arrhythmia’s.  After menopause it is known that the microvascular atherosclerosis can progress towards more pronounced atherosclerosis with eventually obstructive plaque formation.


It is this combination of non-obstructive cardiovascular disease with loss of endothelial function in the epicardial and microvascular beds which can lead to chest pain which is not wel understood.   
It is this combination of non-obstructive cardiovascular disease with loss of endothelial function in the epicardial and microvascular beds which can lead to chest pain which is not well understood.   


For women with evidence of ischemia but no obstructive CAD, anti-anginal and anti-ischemic therapies can improve symptoms, endothelial function, and quality of life; however, trials evaluating impact on adverse outcomes are needed. Women experience more adverse outcomes compared with men because obstructive CAD remains the current focus of therapeutic strategies. Continued research is indicated to devise therapeutic regimens to improve symptom burden and reduce risk in women with ischemic heart disease.  
For women with evidence of ischemia but no obstructive CAD, anti-anginal and anti-ischemic therapies can improve symptoms, endothelial function, and quality of life; however, trials evaluating impact on adverse outcomes are needed. Women experience more adverse outcomes compared with men because obstructive CAD remains the current focus of therapeutic strategies. Continued research is indicated to devise therapeutic regimens to improve symptom burden and reduce risk in women with ischemic heart disease.  
Line 47: Line 46:


===Smoking===
===Smoking===
Smoking is the single most important preventable cause of IHD in women. It
Smoking is the single most important preventable cause of IHD in women. It is a relatively large risk factor for myocardial infarction in women under the age of 55 when compared to men. Smoking enhances the inflammatory process, activates the coagulation system en promotes LDL oxidation. Smoking leads to down-regulation of the estrogen receptor in the endothelial wall leading to endothelial dysfunction and atherosclerosis. The combination of smoking and the use of oral contraceptives has a synergistic effect by inducing endothelial dysfunction and activation of the coagulation system. After cessation the risk declines rapidly.
is a relatively large risk factor for myocardial infarction in women under the age of 55 when compared to men. Smoking enhances the inflammatory process, activates the coagulation system en promotes LDL oxidation. Smoking leads to down-regulation of the estrogen receptor in the endothelial wall leading to endothelial dysfunction and atherosclerosis.The combination of smoking and the use of oral contraceptives has a synergistic effect by inducing endothelial dysfunction and activation of the coagulation system. After cessation the risk declines rapidly.


===Hypertension===
===Hypertension===
Line 54: Line 52:


===Dyslipidemia===
===Dyslipidemia===
In women there is a stronger fluctuation of lipid levels throughout life. Due to hormonal changes total and LDL cholesterol levels increase with an average of 10-14% after menopause( AMp29/ref16). Low HDL and high triglycerides seems to be more important risk factors in women than in men. Data form the Nurses Health Study shows that HDL was the lipid parameter that best discriminated the risk of ischemic heart disease (VACC ref 24).
In women there is a stronger fluctuation of lipid levels throughout life. Due to hormonal changes total and LDL cholesterol levels increase with an average of 10-14% after menopause (AMp29/ref16). Low HDL and high triglycerides seems to be more important risk factors in women than in men. Data from the Nurses Health Study shows that HDL was the lipid parameter that best discriminated the risk of ischemic heart disease (VACC ref 24).
Hypertriglyceridemia is associated with a 37% increase in CVD risk in women compared to 14% in men (VACC 25). The dynamic changes of the lipidprofiles due to age and menopausal status play an important role in the prevention of cardiovascular disease in women.  
Hypertriglyceridemia is associated with a 37% increase in CVD risk in women compared to 14% in men (VACC 25). The dynamic changes of the lipidprofiles due to age and menopausal status play an important role in the prevention of cardiovascular disease in women.  


===Obesity===
===Obesity===
Obesity is an important risk factor for diabetes, hypertension and cardiovascular disease. There is a gradient of coronary risk with increasing overweight, with the heaviest category of women having a four-fold increased risk for CVD compared with lean women. Around menopause there is a shift from gynoid fat distribution to android. This central obesity in women leads more than in men to the metabolic syndrome, with an increased relative risk of insulin resistance, dyslipidemia and hypertension.  
Obesity is an important risk factor for diabetes, hypertension and cardiovascular disease. There is a gradient of coronary risk with increasing overweight, with the heaviest category of women having a four-fold increased risk for CVD compared with lean women. Around menopause there is a shift from gynoid fat distribution to android. This central obesity in women leads more than in men to the metabolic syndrome, with an increased relative risk of insulin resistance, dyslipidemia and hypertension.  


===Diabetes===
===Diabetes===
Diabetes is associated with a higher risk for ischemic heart disease in women than in men (RR2.0). This is partly due to a higher rate of coexisting risk factors in women with diabetes compared to men. Another important factor is that diabetes is more difficult to treat since less women reach treatment goals when compared to men. In women diabetes is a independent risk factor for developing heart failure. Diabetes during pregnancy has a 7-12 fold risk for developing diabetes later in life.
Diabetes is associated with a higher risk for ischemic heart disease in women than in men (RR2.0). This is partly due to a higher rate of coexisting risk factors in women with diabetes compared to men. Another important factor is that diabetes is more difficult to treat since less women reach treatment goals when compared to men. In women diabetes is an independent risk factor for developing heart failure. Diabetes during pregnancy has a 7-12 fold risk for developing diabetes later in life.


===Women specific risk factors===
===Women specific risk factors===
Line 67: Line 65:


=== “Novel” risk factors===
=== “Novel” risk factors===
In an effort to make a more accurate estimation of cardiovascular risk, more than 100 new risk markers have been proposed. There is however a slight resistance to use these markers since the lack of evidence that they really make risk estimation more accurate. A recent summary of systematic reviews conducted for the United states Preventive Services Task force has reviewed the evidence of 9 novel risk factors (Table 1). Of the risk markers evaluated C-reactive protein was the best candidate for screening, however, evidence is still lacking to recommend routine use. The Reynolds Risk score, which is a risk score specifically designed for women, incorporated CRP which reclassified 15 % of the intermediate risk women to high risk.
In an effort to make a more accurate estimation of cardiovascular risk, more than 100 new risk markers have been proposed. There is however a slight resistance to use these markers since the lack of evidence that they really make risk estimation more accurate. A recent summary of systematic reviews conducted for the United States Preventive Services Task force has reviewed the evidence of 9 novel risk factors (Table 1). Of the risk markers evaluated C-reactive protein was the best candidate for screening, however, evidence is still lacking to recommend routine use. The Reynolds Risk score, which is a risk score specifically designed for women, incorporated CRP which reclassified 15 % of the intermediate risk women to high risk.


===Depression & Acute stress===
===Depression & Acute stress===
Data form the INTERHEART study shows, that particular in women the combined exposure psychological risk factors such as depression, chronic emotional distress and acute stress such as major live events, are significantly associated with acute myocardial infarction (OR 2.6 in men and 3.5 in women). A stress-induced condition known as “Takotsubo cardiomyopathy” is almost exclusively seen among women. Due to severe emotional stress these women present with symptoms mimicking acute myocardial infarction. Also the ECG and echocardiogram show all the signs of infarction. However the the CAG is often normal with no signs of coronary obstruction. The severe impaired left ventricular function usually normalizes completely after a couple of months.  
Data from the INTERHEART study shows, that particular in women the combined exposure psychological risk factors such as depression, chronic emotional distress and acute stress such as major live events, are significantly associated with acute myocardial infarction (OR 2.6 in men and 3.5 in women). A stress-induced condition known as “Takotsubo cardiomyopathy” is almost exclusively seen among women. Due to severe emotional stress these women present with symptoms mimicking acute myocardial infarction. Also the ECG and echocardiogram show all the signs of infarction. However the CAG is often normal with no signs of coronary obstruction. The severe impaired left ventricular function usually normalizes completely after a couple of months.  


==Risk Factor Assessment==
==Risk Factor Assessment==
Line 76: Line 74:
Global cardiovascular risk should be assessed in all women in menopause consulting the physician.
Global cardiovascular risk should be assessed in all women in menopause consulting the physician.


Many women appear healthy wit hno symptoms of CVD nevertheless, they are potentially at increased risk
Many women appear healthy with no symptoms of CVD nevertheless, they are potentially at increased risk


The following risk factors should be assessed
The following risk factors should be assessed
Line 87: Line 85:
*Personal and family history of cardiovascular disease
*Personal and family history of cardiovascular disease
*Gynecological and obstetric history, including age at menopause
*Gynecological and obstetric history, including age at menopause
‘body weight
*Body weight
*Waist circumference
*Waist circumference
*Diet
*Diet
Line 107: Line 105:


==Clinical Presentation==
==Clinical Presentation==
The clinical presentation of cardiac complaints differ between men and women. Female patients as well as their treating physicians often do not recognize or interpret their complaints as heart problems. Women present less typical as what we are used when men present with heart problems. Typical symptoms, as we have learned from our male patients, such as heavy pressure on the chest which radiates to the left arm or the jaws are often absent in women. Women more often present with complaints such as “tightness” , “out of breath” en “tiredness”. When women get older (>60 yrs) and the risk of obstructive coronary artery disease rises, the clinical presentation becomes more typical (substernal pain, with radiation to jaw and/or left arm).  
The clinical presentation of cardiac complaints differ between men and women. Female patients as well as their treating physicians often do not recognize or interpret their complaints as heart problems. Women present less typical as what we are used when men present with heart problems. Typical symptoms, as we have learned from our male patients, such as heavy pressure on the chest which radiates to the left arm or the jaws are often absent in women. Women more often present with complaints such as “tightness”, “out of breath” en “tiredness”. When women get older (>60 yrs) and the risk of obstructive coronary artery disease rises, the clinical presentation becomes more typical (substernal pain, with radiation to jaw and/or left arm).  


As a result women are often not recognized and do not receive the proper preventive medication. This could in part explain the higher mortality of cardiovascular diseases in women.
As a result women are often not recognized and do not receive the proper preventive medication. This could in part explain the higher mortality of cardiovascular diseases in women.
Line 113: Line 111:
Women who are diagnosed with non cardiac chest pain have twofold increased risk to develop a coronary event in the next 5-7 years and have a four times higher risk for re-hospitalization. This implicates that diagnostic testing is limited and that women should be more aggressively treated for their risk factors.
Women who are diagnosed with non cardiac chest pain have twofold increased risk to develop a coronary event in the next 5-7 years and have a four times higher risk for re-hospitalization. This implicates that diagnostic testing is limited and that women should be more aggressively treated for their risk factors.


Chest pain syndromes are more common in women then in men and are less related to the presence of atherosclerosis in the epicardial coronary arteries.(Eur.H J/2006;27:2285-93).  
Chest pain syndromes are more common in women then in men and are less related to the presence of atherosclerosis in the epicardial coronary arteries. (Eur.H J/2006;27:2285-93).  


There are no gender-specific criteria for the interpretation of ECG’s. Non specific ECG changes at rest, a lower exercise capacity and a smaller vessel size contribute to the lower sensitivity and specificity of non-invasive testing in women. At younger ages, endogenous estrogen level scan induce ECG changes mimicking ischemia.  
There are no gender-specific criteria for the interpretation of ECG’s. Non specific ECG changes at rest, a lower exercise capacity and a smaller vessel size contribute to the lower sensitivity and specificity of non-invasive testing in women. At younger ages, endogenous estrogen level scan induce ECG changes mimicking ischemia.  


Chest pain complaints in women should always be related to their risk factor profile. It should also be noted that in women, very often chest pain is related to not well regulated hypertension. Blood pressure changes increase vascular wall pressure of the coronary arteries which translates in chest discomfort often at rest. In addition hypertension more often leads to diastolic dysfunction in women en hypertrophy which can result in chest pain. A small dose of nitrates can be effective.
Chest pain complaints in women should always be related to their risk factor profile. It should also be noted that in women, very often chest pain is related to not well regulated hypertension. Blood pressure changes increase vascular wall pressure of the coronary arteries which translates in chest discomfort often at rest. In addition hypertension more often leads to diastolic dysfunction in women en hypertrophy which can result in chest pain. A small dose of nitrates can be effective.


==Treatment==
==Treatment==
Line 132: Line 130:


====Diet: TARGET: Adopt healthy diet====
====Diet: TARGET: Adopt healthy diet====
*Explain importance of a varied diet and the need to adjust energy intake to achieve And maintain ideal body weight.
*Explain importance of a varied diet and the need to adjust energy intake to achieve and maintain ideal body weight.
*Encourage the consumption of:
*Encourage the consumption of:
**Fruits and vegetables (the five-a-day guideline)
**Fruits and vegetables (the five-a-day guideline)
Line 151: Line 149:
*A health women should exercise at 60-75% of the average maximum heart rate
*A health women should exercise at 60-75% of the average maximum heart rate


====Obesity:TARGET: Body Mass Index < 25 kg.m2 or waist circumference < 88====
====Obesity: TARGET: Body Mass Index < 25 kg.m2 or waist circumference < 88====
*Explain that by consuming 500-1000 calories/day less than required to maintain het current weight, she can lode about 500 grams/week and ultimately achieve weight loss of 5-15%
*Explain that by consuming 500-1000 calories/day less than required to maintain the current weight, she can lose about 500 grams/week and ultimately achieve weight loss of 5-15%
*Stress that regular exercise assists in weight loss
*Stress that regular exercise assists in weight loss
*Give diet advice (as described earlier)
*Give diet advice (as described earlier)
Line 163: Line 161:


===Post-menopausal hormone therapy===
===Post-menopausal hormone therapy===
The initation or continuation of hormone replacement therapy should be decided according to the individual patient. Given the many potentially beneficial effects of estrogens on cardiovascular physiology, much expectation was placed on hormone therapy for CVD prevention. However several studies did not support benificial effects of hormone therapy and in the WHI study (womens health initiative) the study was terminated due to a small increase in CVD.  In a woman < 60 years, who recently menopaused with menopausal symptoms and without CVD, the initiation of replacement therapy does not cause early harm. If a women is at increased risk, HRT therapy is safe to use in the younger women with indications. It should be notes however, that HRT should not be initiated solely for the prevention of cardiovascular disease and should not be regarded as a substitute for antihypertensive treatment.
The initation or continuation of hormone replacement therapy should be decided according to the individual patient. Given the many potentially beneficial effects of estrogens on cardiovascular physiology, much expectation was placed on hormone therapy for CVD prevention. However several studies did not support beneficial effects of hormone therapy and in the WHI study (women's health initiative) the study was terminated due to a small increase in CVD.  In a woman < 60 years, who recently menopaused with menopausal symptoms and without CVD, the initiation of replacement therapy does not cause early harm. If a woman is at increased risk, HRT therapy is safe to use in the younger women with indications. It should be notes however, that HRT should not be initiated solely for the prevention of cardiovascular disease and should not be regarded as a substitute for antihypertensive treatment.


==Conclusions==
==Conclusions==
Line 182: Line 180:
!colspan="2"|CASE 1: 60- year old woman with risk factor (mis)management
!colspan="2"|CASE 1: 60- year old woman with risk factor (mis)management
|-
|-
|colspan="2"|Patient presented at the emergency room with atypical complaints. She was nauseaus had a burning sensation on het chest. She had consulted her GP several times with atypical chest pain. No further action was taken then.
|colspan="2"|Patient presented at the emergency room with atypical complaints. She was nauseaus had a burning sensation in the chest. She had consulted her GP several times with atypical chest pain. No further action was taken then.
|-
|-
|'''History:'''  
|'''History:'''  
|Several weeks of extreme tiredness, burning chestpains, not related to excercise.
|Several weeks of extreme tiredness, burning chest pains, not related to exercise.
|-
|-
|'''Riskfactors:'''  
|'''Risk factors:'''  
|Her father had his First heart atack at age 50. She had hypertension during both pregnancies.Menopausa She menopaused at age 46 with a lot of menopausal complaints such as flushes. She had a smoking history of 10 years.,
|Her father had his First heart attack at age 50. She had hypertension during both pregnancies. Menopausa She menopaused at age 46 with a lot of menopausal complaints such as flushes. She had a smoking history of 10 years.  
|-
|-
|'''Physical examination:'''  
|'''Physical examination:'''  
|BMI=26, bloodpressure: 180/100 mmHg, pulse: 80 r.a., normal heart sounds, grade II/VI systolic murmur.  
|BMI=26, blood pressure: 180/100 mmHg, pulse: 80 r.a., normal heart sounds, grade II/VI systolic murmur.  
|-
|-
|'''Lab: glucose:'''  
|'''Lab: glucose:'''  
Line 197: Line 195:
|-
|-
|width="13%"|'''Additional Cardiac Investigation:'''  
|width="13%"|'''Additional Cardiac Investigation:'''  
|ECG showed T-wave inversion in the precordial leads. Cardiac enzymes were positive. Cardiac catheterization showed an 80% stenosis of the left main coronary artery. The echocardiogram show wall segment disorders of the anterior wall and a grad II mitral valave insufficiency.
|ECG showed T-wave inversion in the precordial leads. Cardiac enzymes were positive. Cardiac catheterization showed an 80% stenosis of the left main coronary artery. The echocardiogram show wall segment disorders of the anterior wall and a grad II mitral valve insufficiency.
|-
|-
|'''Follow-up:'''  
|'''Follow-up:'''  
|She received PTCA of the left main en her lipid profile and bloodpressure was treated. She recovered and is doing well.  
|She received PTCA of the left main en her lipid profile and blood pressure was treated. She recovered and is doing well.  
|-
|-
|'''Learning points:'''
|'''Learning points:'''
|
|
*Atypical presenttion of acute coronary syndrome
*Atypical presentation of acute coronary syndrome
*In women cardiac complaints are often atypical
*In women cardiac complaints are often atypical
*She was not categorized as a high risk patient
*She was not categorized as a high risk patient
Line 215: Line 213:
!colspan="2"|Case 2: 52-year old woman with microvascular disease
!colspan="2"|Case 2: 52-year old woman with microvascular disease
|-
|-
|colspan="2"|Patient is referred for a second opionion to the cardiologist with complaints of tiredness and chestpain. She was evaluated 3 months earlier with chestpain. Cardiovascualr analysis then showed no cardiac pathology.  
|colspan="2"|Patient is referred for a second opinion to the cardiologist with complaints of tiredness and chest pain. She was evaluated 3 months earlier with chest pain. Cardiovascualr analysis then showed no cardiac pathology.  
|-
|-
|'''History:'''  
|'''History:'''  
|Patient, who runs every week 10 kilometers, complains that she noticed shortness of breath and tiredness during her weekly run which she describes as abnormal. During running she has no chestpain. She does however experience chestpain, which she describes as “heavy”feeling on the chest, when there is an abrupt change of temperature. Als slight radiation to the left arm.
|Patient, who runs every week 10 kilometers, complains that she noticed shortness of breath and tiredness during her weekly run which she describes as abnormal. During running she has no chest pain. She does however experience chest pain, which she describes as “heavy" feeling on the chest, when there is an abrupt change of temperature. Also slight radiation to the left arm.
|-
|-
|'''Riskfactors:'''  
|'''Risk factors:'''  
|Menopausal, positive family history, smoking history (she quit 15 years ago ), obstetric history normal, Alcohol consumption: 2U/day
|Menopausal, positive family history, smoking history (she quit 15 years ago), obstetric history normal, Alcohol consumption: 2U/day
|-
|-
|'''Physical examination:'''  
|'''Physical examination:'''  
|BMI=26, bloodpressure: 145/90 mmHg, pulse: 70 r.a., normal heart sounds, no murmurs.  
|BMI=26, blood pressure: 145/90 mmHg, pulse: 70 r.a., normal heart sounds, no murmurs.  
|-
|-
|'''Lab: glucose:'''  
|'''Lab: glucose:'''  
Line 230: Line 228:
|-
|-
|width="13%"|'''Additional Cardiac Investigation:'''  
|width="13%"|'''Additional Cardiac Investigation:'''  
|ECG and exercise stress test were completely normal. Vascular scanning of the carotis arteries showed moderatie plaqueformation in de the carotid bulb.  No chestpain during excercise. Myocardial perfusion scan showed ischemia in the inferior segments of the heart. Cardiac catheterization: vessel wall irregularities in all coronary arteries, no significant obstructions.
|ECG and exercise stress test were completely normal. Vascular scanning of the carotis arteries showed moderatie plaqueformation in de the carotid bulb.  No chest pain during exercise. Myocardial perfusion scan showed ischemia in the inferior segments of the heart. Cardiac catheterization: vessel wall irregularities in all coronary arteries, no significant obstructions.
|-
|-
|'''Follow-up:'''  
|'''Follow-up:'''  
|Bloodpressure and lipidprofiles was optimized with ACE inhibition and a statine. She was advised to lose weight and drink less alcohol with regard to her elevated triglycerides. She received a low dose b-blokker and was without complaints within 3 months.
|Blood pressure and lipidprofiles was optimized with ACE inhibition and a statine. She was advised to lose weight and drink less alcohol with regard to her elevated triglycerides. She received a low dose b-blocker and was without complaints within 3 months.
|-
|-
|'''Learning points:'''
|'''Learning points:'''
|
|
*Complaints without obstructive heart disease
*Complaints without obstructive heart disease
*Risk factors should always be optimized, bloodpressure en lipide profile was inadequate
*Risk factors should always be optimized, blood pressure in lipidprofile was inadequate
*Limitation of diagnostic tests.
*Limitation of diagnostic tests.
|}
|}


==References==
==References==
<biblio>
#1 World Health Organization. The Global Burden of Disease: 2004 Update. Geneva: World Health Organization; 2008. & American Heart Association Statistical Fact Sheet, June 2010.
#2 [http://www.bhf.org.uk/publications/view-publication.aspx?ps=1001443 European cardiovascular disease statistics 2008, British Heart Foundation.]
#3 Heron MP, Hoyert DL, Xu J, Scott C, Tejada-Vera B. Deaths: preliminary data for 2006. Natl Vital Stat Rep. 2008 Jun 11;56:1–52.
#4 pmid=18036449
#5 pmid=12575968
</biblio>
467

edits